Use your antibodies-online credentials, if available.
抗Human GRM7 抗体:
抗Mouse (Murine) GRM7 抗体:
抗Rat (Rattus) GRM7 抗体:
Cow (Bovine) Polyclonal GRM7 Primary Antibody for IHC (p), WB - ABIN4334140
Friedman, Van Laer, Huentelman, Sheth, Van Eyken, Corneveaux, Tembe, Halperin, Thorburn, Thys, Bonneux, Fransen, Huyghe, Pyykkö, Cremers, Kremer, Dhooge, Stephens, Orzan, Pfister, Bille, Parving et al.: GRM7 variants confer susceptibility to age-related hearing impairment. ... in Human molecular genetics 2009
Show all 2 Pubmed References
Human Polyclonal GRM7 Primary Antibody for ELISA, WB - ABIN541133
Vadasz, Saito, Gyetvai, Oros, Szakall, Kovacs, Prasad, Toth: Glutamate receptor metabotropic 7 is cis-regulated in the mouse brain and modulates alcohol drinking. in Genomics 2007
The mutant allele C in rs1485175 of the GMR7 may decrease individuals' susceptibility to noise-induced hearing loss.
The results of this study indicate that the GRM7 rs9814881 might be associated with MDD in the Chinese Han population.
study to evaluate evidence for association between GRM7 and alcohol behaviors using an SNP approach, as well as a gene-based approach in two independent samples; Rs3749380 was suggestively associated with alcohol consumption in one sample with the minor T allele conferring risk; there was no evidence for association in the other sample
Autism spectrum disorder (ASD) as a synaptopathy is revealed to be pertained to aberrant glutamatergic neurotransmission. Glutamate receptor, metabotropic 7 (GRM7) is a receptor coding gene of this pathway.
GRM7 rs2133450 may have translational relevance as a predictor of response to risperidone in schizophrenia.
Multiple genetic models identified 1 significant locus, GRM7, for 2 hypertension-derived traits.
Study represents a genetic association test towards single variant and multi-markers interaction of GRM7 and GRM8 genes in both schizophrenia and major depressive disorders in Han Chinese population
Glutamate system genes have been associated with disease risk in recent analyses from the Psychiatric Genomics Consortium.
results indicate that the GRM7 SNPs rs13353402 and rs1531939 might be associated with schizophrenia in Chinese Han population.
results reported here do not support a role for GRM7 in ADHD
Copy number variants at GRM7 may have a role in the etiology of bipolar disorder.
For neither PCLO nor GRM7 we found a more associated variant. For SLC6A4, we found a new SNP that showed a lower P-value than in the GAIN-MDD GWAS
in an elderly male Han Chinese population, GRM7 SNP rs11928865 (TT) occurs more frequently in age-related hearing impairment patients with SL and AL phenotype patterns.
These results provide preliminary evidence of an association between the GRM7 rs37952452 polymorphism and selective attention deficit and anxiety found within the Korean ADHD population
Mixed modeling analyses explored the relationship of GRM7 haplotype and SNP genotypes with measures of auditory perception. GRM7 alleles are associated primarily with peripheral measures of hearing loss, and with speech detection in older adults.
SNPs in autism spectrum disorders
Copy number variations within GRM7 are not associated with schizophrenia in the Han Chinese population.
This suggests that 3p25-26 is a new locus for severe recurrent depression. This represents the first report of a genome-wide significant locus for depression that also has an independent genome-wide significant replication.
In the Australian heavy smoking families, the authors found a genome-wide significant multipoint LOD score of 4.14 for major depressive disorder on chromosome 3 at 24.9 cM (3p26-3p25).
Data sets demonstrated a region of association for major depressive disorder within GRM7. Thus, the significance of this finding remains uncertain.
mGlu7 may be a potential therapeutic target for multiple aspects of the Rett phenotype.
The mGlu7 receptor was found to be involved in a wide range of behavioral and physiological alterations in response to chronic psychosocial stress exposure.
This study provides evidence for mGlu7 receptor-mediated tonic modulation of a physiological function in vivo preventing synchronous and potentially pathological oscillations.
Analysis of mGluR7 KO mice, c-Fos expression, and cerebral MMPIP microinjection indicate that inhibition of mGluR7 impairs intermale aggression owing to information processing dysfunction within the bed nucleus of the stria terminalis
muscle does not appear to require high levels of SMN above what is produced by two copies of SMN2
SAM68 is a physiological regulator of SMN2 splicing in a spinal muscular atrophy mouse model.
Hyperoxia treatment increased the inclusion of SMN2 exon 7 in skeletal muscles and resulted in improved motor function.
Elfn1 recruits mGluR7 to synaptic sites.A trans interaction of Elfn1 and mGluR7 controls targeted interneuron synapse development.
GRM7 regulates the phosphorylation of CREB protein and the expression of Yes-associated protein (YAP) by directly interacting with CaM, which subsequently regulates the expression of CyclinD1 and ultimately affects early cortical development.
Modeling the selective interaction between XAP044 and mGlu7's Venus flytrap domain, whose three-dimensional structure is already known, will facilitate future drug development supported by computer-assisted drug design
The data of this study revealed very different roles for mGlu7 in amygdala synaptic transmission, fear learning and its expression
These data suggest targeting mGlu7 receptors with selective antagonist drugs may be an effective and safe strategy for the treatment of anxiety disorders.
Glutamate release mediated by GluR7 at nerve terminals is influenced by divalent calcium channel type Ca2+ ionophore.
mGluR7, by affecting the cofilin/actin signaling, regulates NMDAR trafficking and function
The genomic integration site of the mGluR7 transgene is in intron 4 in spinal muscular atrophy transgenic mice, especially those that have extended survival.
Phorbol esters and prolonged activation of mGlu7 receptors both potentiate glutamate release via a common intracellular signalling pathway that occurs in nerve terminals containing N-type divalent calcium channels.
This study suggested that mGlu7 receptor is involved in the regulation of GABAergic system activity at the level of GABA synthesised enzymes, specific proteins expressed by GABAergic neurons and metabotropic receptor for GABA.
mGlu7 receptors may not only regulate the central components of chronic stress, but may also have a role in the regulation of fluid & electrolyte transport which is significantly disrupted in diseases such as IBS, by enhancing colonic secretory activity
The mGluR7 may play a pivotal role in mechanisms that regulate behavioural responses to aversive states. Therefore, drugs acting at mGluR7 may provide novel treatments for psychiatric disorders such as depression and anxiety.
genetic ablation of mGluR7 in mice interferes at multiple sites in the neuronal circuitry and molecular pathways implicated in affective disorders.
L-glutamate is the major excitatory neurotransmitter in the central nervous system, and it activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors that have been divided into three groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5, and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3, while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Multiple transcript variants encoding different isoforms have been found for this gene.
metabotropic glutamate receptor 7
, G protein-coupled receptor GRM7
, G protein-coupled receptor, family C, group 1, member G
, mGlu7a receptor
, metabotropic glutamate receptor mGluR7
, metabotropic glutamate receptor subtype 7b